Dr. Steve Dunder, MD
Claim this profileSoutheast Nebraska Cancer Center
Studies Tumors
Studies B Cell Malignancies
1 reported clinical trial
1 drug studied
Affiliated Hospitals
More about Steve Dunder, MD
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Steve Dunder, MD has experience with
- Orelabrutinib (ICP-022)
Breakdown of trials Steve Dunder, MD has run
B Cell Malignancies
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Steve Dunder, MD specialize in?
Steve Dunder, MD focuses on Tumors and B Cell Malignancies. In particular, much of their work with Tumors has involved treating patients, or patients who are undergoing treatment.
Is Steve Dunder, MD currently recruiting for clinical trials?
No, Steve Dunder, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Steve Dunder, MD has studied deeply?
Yes, Steve Dunder, MD has studied treatments such as Orelabrutinib (ICP-022).
What is the best way to schedule an appointment with Steve Dunder, MD?
Apply for one of the trials that Steve Dunder, MD is conducting.
What is the office address of Steve Dunder, MD?
The office of Steve Dunder, MD is located at: Southeast Nebraska Cancer Center, Lincoln, Nebraska 68510-2496 United States. This is the address for their practice at the Southeast Nebraska Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.